Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 15Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma 9Myelodysplastic Syndromes 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Multiple Myeloma 5Myeloproliferative Disorders 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Graft vs Host Disease 4Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Congenital Abnormalities 3Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Diseases 2Blast Crisis 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Unrecognized Condition: Mature B or T-cell Neoplasm 1Thrombocythemia, Essential 1Thalassemia 1Primary Myelofibrosis 1

Interventions

fludarabine 1Sertraline 1Melphalan 1Biopsy 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Preleukemia × Alemtuzumab × Clear all
NCT00943293 2014-03-17

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

University of Chicago

Phase 1 Terminated
1 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Myeloproliferative Disorders, Preleukemia, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡